EUVIMEDEUVIMED entdecken
VergleichsstudieMetaanalyseSystematische Übersicht

Comparing the efficacy and safety of endovascular therapy versus surgical revascularization for critical limb-threatening ischemia: A systematic review and Meta-analysis

Mohamad Riad Abouzid, Ankit Vyas, Ibrahim Kamel, Junaid Anwar, Shorouk Elshafei, Venkat Subramaniam, William Bennett, Carl J Lavie, Chima Nwaukwa, Christopher J White, Rajan A G Patel

Progress in Cardiovascular Diseases · 2025-01 · 88 · 126-135

DOI: 10.1016/j.pcad.2024.06.008 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Progress in Cardiovascular Diseases, 2025-01. Verfasst von Mohamad Riad Abouzid und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Baptist Hospitals of Southeast Texas, Beaumont, TX, United States of America. Hauptthemen laut MEDLINE: Endovascular Procedures, Ischemia, Peripheral Arterial Disease, Vascular Surgical Procedures. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Critical limb-threatening ischemia (CLTI) is a severe manifestation of peripheral artery disease (PAD) that can lead to limb amputation and significantly reduce quality of life. In addition to guideline-directed medical therapy (GDMT), endovascular therapy and surgical revascularization are the two revascularization options for CLTI. In recent years, there has been an ongoing debate about the best approach for CLTI patients. The purpose of this meta-analysis is to examine the current evidence and compare the clinical outcomes of endovascular therapy and surgical revascularization for CLTI. METHODS: We conducted a systematic search of electronic databases (PubMed, Embase, Cochrane Library, and Web of Science) for studies comparing the outcomes of endovascular therapy versus surgery in patients with CLTI. The primary outcomes were major adverse limb events (MALE) and major adverse cardiovascular events (MACE), while secondary outcomes included risk of bleeding, wound complications, readmission, unplanned reoperation, acute renal failure, and length of hospital stay. Pooled data was analyzed using the fixed-effect model or the random-effect model in Review Manager 5.3. The Newcastle-Ottawa Scale and Cochrane risk of bias assessment tool were used to assess the bias of included studies. RESULTS: A total of 16 studies (47,609 patients) were included in this meta-analysis. The overall effect favors surgery over endovascular intervention in terms of MALE [odds ratio (OR) 1.13, 95% CI (1.01-1.28), P = 0.04]. Endovascular therapy is associated with lower MACE rates compared to surgery [OR 0.62, 95% CI (0.51-0.76), P < 0.00001]. Furthermore, the risk of bleeding, wound complications, readmission, unplanned reoperation, acute renal failure as well as the length of hospital stay was lower for endovascular intervention. Finally, there was no statistically significant difference in 30-day mortality between the two groups [OR 0.94, 95% CI 0.79-1.12, P = 0.52; Fig. 3i], and the pooled studies were homogeneous [P = 0.39; I2 = 5%]. CONCLUSION: Surgery may be the preferred treatment option for CLTI patients, as it is associated with a lower risk of MALE than endovascular therapy. However, endovascular therapy may be associated with a lower risk of MACE and lower rates of bleeding, wound complications, readmission, unplanned reoperation, acute renal failure, and shorter hospital stays. There was no statistically significant difference in 30-day mortality between the two groups. Ultimately, the decision to use endovascular therapy or surgery as the primary treatment strategy should be based on a multi-disciplinary team approach with careful consideration of patient characteristics and anatomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endovascular ProceduresIschemiaPeripheral Arterial DiseaseVascular Surgical ProceduresHumansCritical IllnessLimb SalvagePostoperative ComplicationsRisk AssessmentRisk FactorsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

Critical limb-threatening ischemiaEndovascular therapyPeripheral artery diseaseSurgical revascularization

Autor:innen und Institutionen

  • Department of Internal Medicine, Baptist Hospitals of Southeast Texas, Beaumont, TX, United States of America.
  • Department of Cardiology, Ochsner Clinic Foundation, New Orleans, LA, United States of America.
  • Department of Internal Medicine, Carney Hospital, Dorchester, MA, United States of America.
  • Department of Cardiology, Ochsner Clinic Foundation, New Orleans, LA, United States of America. Electronic address: rapatel@ochsner.org.

Zitieren

APA

Abouzid, M. R., Vyas, A., Kamel, I., Anwar, J., Elshafei, S., Subramaniam, V., Bennett, W., Lavie, C. J., Nwaukwa, C., White, C. J., & Patel, R. A. G. (2025). Comparing the efficacy and safety of endovascular therapy versus surgical revascularization for critical limb-threatening ischemia: A systematic review and Meta-analysis. Progress in Cardiovascular Diseases, 88, 126-135. https://doi.org/10.1016/j.pcad.2024.06.008

Vancouver

Abouzid MR, Vyas A, Kamel I, Anwar J, Elshafei S, Subramaniam V, et al. Comparing the efficacy and safety of endovascular therapy versus surgical revascularization for critical limb-threatening ischemia: A systematic review and Meta-analysis. Progress in Cardiovascular Diseases. 2025;88:126-135. doi:10.1016/j.pcad.2024.06.008

BibTeX
@article{Abouzid2025,
  author = {Abouzid, Mohamad Riad and Vyas, Ankit and Kamel, Ibrahim and Anwar, Junaid and Elshafei, Shorouk and Subramaniam, Venkat and Bennett, William and Lavie, Carl J and Nwaukwa, Chima and White, Christopher J and Patel, Rajan A G},
  title = {Comparing the efficacy and safety of endovascular therapy versus surgical revascularization for critical limb-threatening ischemia: A systematic review and Meta-analysis},
  journal = {Progress in Cardiovascular Diseases},
  year = {2025},
  volume = {88},
  pages = {126--135},
  doi = {10.1016/j.pcad.2024.06.008}
}
Kostenlos starten →